XML 34 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

Basis of Presentation (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2025
Basis of Presentation |
Schedule of computation of basic and diluted earnings per share | ​ The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended March 31, |  | Nine Months Ended March 31,
​ | ​ | 2024 |  | 2025 |  | 2024 |  | 2025
Net income available to common stockholders | ​ | $ | 34,043 | ​ | $ | 41,134 | ​ | $ | 83,475 | ​ | $ | 96,889
Weighted average shares outstanding—basic | ​ |  | 17,042 | ​ | ​ | 16,781 | ​ |  | 16,954 | ​ |  | 16,749
Dilutive effect of equity awards | ​ |  | 383 | ​ | ​ | 378 | ​ |  | 347 | ​ |  | 340
Weighted average shares outstanding—diluted | ​ |  | 17,425 | ​ | ​ | 17,159 | ​ |  | 17,301 | ​ |  | 17,089
Basic earnings per share | ​ | $ | 2.00 | ​ | $ | 2.45 | ​ | $ | 4.92 | ​ | $ | 5.78
Diluted earnings per share | ​ | $ | 1.95 | ​ | $ | 2.40 | ​ | $ | 4.82 | ​ | $ | 5.67
Shares excluded from diluted earnings per share due to their anti-dilutive effect | ​ | ​ | 22 | ​ | ​ | 16 | ​ | ​ | 11 | ​ | ​ | 10
​
Schedule of fair values of our financial assets and liabilities | The fair values of our financial assets and liabilities are categorized as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, 2024 |  | March 31, 2025
​ |  | Level 1 |  | Level 2 |  | Level 3 |  | Total |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets—Insurance company contracts | ​ | $ | — | ​ | $ | 49,679 | ​ | $ | — | ​ | $ | 49,679 | ​ | $ | — | ​ | $ | 52,642 | ​ | $ | — | ​ | $ | 52,642
Assets – Interest rate swap contract | ​ | $ | — | ​ | $ | 4,735 | ​ | $ | — | ​ | $ | 4,735 | ​ | $ | — | ​ | $ | 1,473 | ​ | $ | — | ​ | $ | 1,473
Liabilities—Convertible debt | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | 436,706 | ​ | $ | — | ​ | $ | 436,706
Liabilities—Contingent consideration | ​ | $ | — | ​ | $ | — | ​ | $ | 15,375 | ​ | $ | 15,375 | ​ | $ | — | ​ | $ | — | ​ | $ | 21,542 | ​ | $ | 21,542
Schedule of effect of the cash flow hedges on other comprehensive income (loss) and earnings | The effect of the cash flow hedges on other comprehensive income (loss) and earnings for the periods presented was as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended March 31, |  | Nine Months Ended March 31,
​ | ​ | 2024 |  | 2025 | ​ | 2024 |  | 2025
Total interest and other expense, net presented in the condensed consolidated statements of operations in which the effects of cash flow hedges are recorded | ​ | $ | (7,407) | ​ | $ | (8,228) | ​ | $ | (19,689) | ​ | $ | (24,206)
Gain (loss) recognized in other comprehensive income (loss), net of tax | ​ | $ | 1,731 | ​ | $ | (917) | ​ | $ | (512) | ​ | $ | (2,455)
Amount reclassified from accumulated other comprehensive income (loss) to interest expense, net | ​ | $ | 897 | ​ | $ | 449 | ​ | $ | 2,681 | ​ | $ | 1,984

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4C -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C + Details
Name: | us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration